Lipocine
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$16.14M N/A	$500K -96.90%	$-2.85M -670.16%	Avg: $16.25M Low: $16.25M High: $16.25M avg. 670.11%	Avg: $32.7M Low: $32.7M High: $32.7M avg. 101.19%	Avg: $50.6M Low: $50.6M High: $50.6M avg. 54.74%
Net Income % change YoY	$-634.39K N/A	$-10.75M -1595.87%	$-16.35M -51.99%	Avg: $-721K Low: $-316.18K High: $-316.18K avg. 95.59%	Avg: $-3.31M Low: $-3.31M High: $-3.31M avg. -360.45%	Avg: $7.06M Low: $7.06M High: $7.06M avg. 312.69%
EBITDA % change YoY	$3.21M N/A	$-11.54M -459.35%	$-16.32M -41.36%	Avg: $-5.85M Low: $-5.85M High: $-5.85M avg. 64.13%	Avg: $-11.77M Low: $-11.77M High: $-11.77M avg. -101.19%	Avg: $-18.22M Low: $-18.22M High: $-18.22M avg. -54.74%
EPS % change YoY	-$0.12 N/A	-$2.07 -1625%	-$3.14 -51.69%	Avg: -$0.06 Low: -$0.06 High: -$0.06 avg. 98.08%	Avg: -$0.63 Low: -$0.63 High: -$0.63 avg. -950.00%	Avg: $1.34 Low: $1.34 High: $1.34 avg. 312.69%
Operating Expenses % change YoY	$5.32M N/A	$4.06M -23.77%	$15.08M 271.20%	Avg: $285.96M Low: $285.96M High: $285.96M avg. 1796.32%	Avg: $575.35M Low: $575.35M High: $575.35M avg. 101.19%	Avg: $890.29M Low: $890.29M High: $890.29M avg. 54.74%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 15.94% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -316.18K, average is -721K and high is -316.18K.

Wall Street analysts forecast annual average revenue growth of 275.35% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $16.25M, average is $16.25M and high is $16.25M.

Wall Street analysts forecast annual average earnings growth of -179.73% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.06, average is -$0.06 and high is $-0.06.